133 related articles for article (PubMed ID: 21804364)
1. Payment of research subjects for more than minimal risk trials is unethical.
Wong JC; Bernstein M
Am J Med Sci; 2011 Oct; 342(4):294-6. PubMed ID: 21804364
[TBL] [Abstract][Full Text] [Related]
2. Children in Social Research: Do Higher Payments Encourage Participation in Riskier Studies?
Taplin S; Chalmers J; Hoban B; McArthur M; Moore T; Graham A
J Empir Res Hum Res Ethics; 2019 Apr; 14(2):126-140. PubMed ID: 30735083
[TBL] [Abstract][Full Text] [Related]
3. Economic vulnerability and payment for research participation.
Gelinas L; White SA; Bierer BE
Clin Trials; 2020 Jun; 17(3):264-272. PubMed ID: 32063065
[TBL] [Abstract][Full Text] [Related]
4. Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward.
Largent EA; Fernandez Lynch H
Yale J Health Policy Law Ethics; 2017; 17(1):61-141. PubMed ID: 29249912
[TBL] [Abstract][Full Text] [Related]
5. Paying Participants in COVID-19 Trials.
Largent EA; Lynch HF
J Infect Dis; 2020 Jul; 222(3):356-361. PubMed ID: 32469074
[TBL] [Abstract][Full Text] [Related]
6. Informative inducement: study payment as a signal of risk.
Cryder CE; John London A; Volpp KG; Loewenstein G
Soc Sci Med; 2010 Feb; 70(3):455-464. PubMed ID: 19926187
[TBL] [Abstract][Full Text] [Related]
7. How to do research fairly in an unjust world.
Ballantyne AJ
Am J Bioeth; 2010 Jun; 10(6):26-35. PubMed ID: 20526966
[TBL] [Abstract][Full Text] [Related]
8. The influence of risk and monetary payment on the research participation decision making process.
Bentley JP; Thacker PG
J Med Ethics; 2004 Jun; 30(3):293-8. PubMed ID: 15173366
[TBL] [Abstract][Full Text] [Related]
9. Paying hypertension research subjects.
Casarett D; Karlawish J; Asch DA
J Gen Intern Med; 2002 Aug; 17(8):650-2. PubMed ID: 12213148
[TBL] [Abstract][Full Text] [Related]
10. Exploitation in payments to research subjects.
Phillips T
Bioethics; 2011 May; 25(4):209-19. PubMed ID: 19438444
[TBL] [Abstract][Full Text] [Related]
11. An analysis of U.S. practices of paying research participants.
Grady C; Dickert N; Jawetz T; Gensler G; Emanuel E
Contemp Clin Trials; 2005 Jun; 26(3):365-75. PubMed ID: 15911470
[TBL] [Abstract][Full Text] [Related]
12. Undue inducement: the only objection to payment?
VanderWalde A
Am J Bioeth; 2005; 5(5):25-7. PubMed ID: 16179303
[No Abstract] [Full Text] [Related]
13. Payment for research participation: a coercive offer?
Wertheimer A; Miller FG
J Med Ethics; 2008 May; 34(5):389-92. PubMed ID: 18448723
[TBL] [Abstract][Full Text] [Related]
14. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Asch DA
Arch Intern Med; 2004 Apr; 164(7):801-3. PubMed ID: 15078651
[TBL] [Abstract][Full Text] [Related]
15. Payment of trial participants can be ethically sound: moving past a flat rate.
Koen J; Slack C; Barsdorf N; Essack Z
S Afr Med J; 2008 Dec; 98(12):926-9. PubMed ID: 19374064
[No Abstract] [Full Text] [Related]
16. Conflicts of interest in research involving human beings.
Greco D; Diniz NM
J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
[TBL] [Abstract][Full Text] [Related]
17. Enrolling the uninsured in clinical trials: an ethical perspective.
Pace C; Miller FG; Danis M
Crit Care Med; 2003 Mar; 31(3 Suppl):S121-5. PubMed ID: 12626956
[TBL] [Abstract][Full Text] [Related]
18. Ethics. Human health research ethics.
Silbergeld E; Lerman S; Hushka L
Science; 2004 Aug; 305(5686):949. PubMed ID: 15310879
[No Abstract] [Full Text] [Related]
19. Why adopt a maximin theory of exploitation?
Wertheimer A; Millum J; Schaefer GO
Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968
[No Abstract] [Full Text] [Related]
20. Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.
Iltis AS
J Med Ethics; 2005 Jul; 31(7):410-4. PubMed ID: 15994362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
